Ascorbate Combination Therapy: New Tool in the Anticancer Toolbox?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Science Translational Medicine

• Publication date

  2014-02-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1126/scitranslmed.3008488PMID 24500402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy

  2014cited by this paper
• Parenteral Ascorbate As a Cancer Therapeutic: A Reassessment Based on Pharmacokinetics

  2013cited by this paper
• Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial

  2013cited by this paper
• Ascorbic Acid and a Cytostatic Inhibitor of Glycolysis Synergistically Induce Apoptosis in Non-Small Cell Lung Cancer Cells

  2013cited by this paper
• Human genetic variation influences vitamin C homeostasis by altering vitamin C transport and antioxidant enzyme function.

  2013cited by this paper
• Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

  2012cited by this paper
• Pharmacological concentrations of ascorbate radiosensitize glioblastoma multiforme primary cells by increasing oxidative DNA damage and inhibiting G2/M arrest.

  2012cited by this paper
• Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.

  2011cited by this paper
• Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities

  2009cited by this paper
• Results from a phase I clinical trial with IGN311, a fully humanized IgG1 antibody against Lewis Y in patients with solid tumors expressing Lewis Y antigen

  2004influential reference
• Potentiation of growth inhibition due to vincristine by ascorbic acid in a resistant human non-small cell lung cancer cell line.

  1995cited by this paper

• Biocompatible hole scavenger-assisted graphene oxide dots for photodynamic cancer therapy.

  2021cites this paper
• Two Distinct Faces of Vitamin C: AA vs. DHA

  2021cites this paper
• Ascorbic Acid Sensitizes Colorectal Carcinoma to the Cytotoxicity of Arsenic Trioxide via Promoting Reactive Oxygen Species-Dependent Apoptosis and Pyroptosis

  2020cites this paper
• Hierarchical Porous Graphene–Iron Carbide Hybrid Derived From Functionalized Graphene-Based Metal–Organic Gel as Efficient Electrochemical Dopamine Sensor

  2020cites this paper
• Ascorbate Combination Therapy: New in the Toolbox?

  2016cites this paper
• Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy

  2016cites this paper
• In situ gel-forming dual drug delivery system for synergistic combination therapy of colorectal peritoneal carcinomatosis

  2015cites this paper
• The Tumorigenic Roles of the Cellular REDOX Regulatory Systems

  2015cites this paper
• Targeting Cancer Metabolism with Ketosis and Hyperbaric Oxygen

  2014cites this paper
• Comparative Performance Assessment of Point-of-Care Testing Devices for Measuring Glucose and Ketones at the Patient Bedside

  2014cites this paper